Charlotte Walbaum

Charlotte Walbaum

Auto-generated profile, based on publicly available information

Charlotte Walbaum

Department of Medical Psychology (C.W., R.P., M.H., J.J., U.K., S.V.), University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology (C.W., C.B., K.O., S.V.), University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 2023 in Psycho-Oncology
Verified
Journal Article
Open access
CWCharlotte Walbaum
Charlotte Walbaum
RPRebecca Philipp
Rebecca Philipp
KOKarin Oechsle
Karin Oechsle
AUAnneke Ullrich
Anneke Ullrich
SVSigrun Vehling
Sigrun Vehling
Objective: Caregiving for a loved one is challenging and requires significant resources. Existential distress in family caregivers may include hopelessness, demoralization, fear of death, pre‐loss grief, or a sense of not being emotionally prepared. The aim of this systematic review is to synthesize the quantitative literature on existential distress among family caregivers of patients with advanced cancer, focusing on its prevalence, association with mental disorders, as well as with sociodemographic, disease, and treatment‐related factors.Methods: We systematically searched electronic databases for quantitative studies of the above‐described existential distress concepts in family caregivers of patients with advanced cancer. Two independent reviewers extracted data and evaluated study quality. Data were analyzed using random‐effects meta‐analysis.Results: We retrieved 17.587 records, of which 31 studies fulfilled inclusion criteria. 63% of the studies (n = 20) provided sufficient data for meta‐analysis for 5558 patients. We found an overall pooled prevalence of 30.6% for existential distress, 95% CI [24.2–37.0]. For existential distress subconcepts, prevalence rates were 57.0%, 95% CI [37.8–76.2], for death anxiety, 13.9%, 95% CI [10.8–17.0], for demoralization, 24.0%, 95% CI [18.0–30.0], for pre‐loss grief, 18.4%, 95% CI [4.0–32.7], for hopelessness, 35.2%, 95% CI [28.2–42.2], for loneliness, and 35.6%, 95% CI [13.0–58.3], for emotional unpreparedness.Conclusions: Approximately one third of the respondents were affected by high levels of existential distress. The review provides evidence for further development of support services that can reduce existential distress, focused on death anxiety, and improve the quality of life for family caregivers of patients with advanced cancer.

28 August 2024 in Journal of Pain and Symptom Management
Verified
Journal Article
Open access
CWCharlotte Walbaum
Charlotte Walbaum
RPRebecca Philipp
Rebecca Philipp
CBCarsten Bokemeyer
Carsten Bokemeyer
MHMartin Härter
Martin Härter
JJJohanna Junghans
Johanna Junghans
SVSigrun Vehling
Sigrun Vehling
Death anxiety is associated with fears of suffering and uncertainty at the end of life. It is also relevant to patients' family caregivers, who can experience fears about the patients' death and dying. This study investigates the prevalence of death anxiety in advanced cancer patients and their family caregivers and its association with sociodemographic and medical characteristics. We recruited patients with UICC stage IV solid tumors from in- and outpatient oncology and palliative care settings. We administered the Death and Dying Distress Scale to assess clinically significant death anxiety. We analyzed its association with sociodemographic and medical characteristics using simultaneous multiple linear regression analyses. Death anxiety was prevalent in 37% of patients (N = 481) and 75% of family caregivers (N = 140). Most frequent death anxiety concerns were "feeling distressed about the impact of one's own death on loved ones" (52% of patients) and "feeling distressed about running out of time with their loved one" (69% of family caregivers). Patients who experienced high death anxiety were more likely to be younger (standardized β = -0.1; P=0.005) and have known about their diagnosis for less time (standardized β = -0.1; P=0.046). Being female predicted higher death anxiety in patients (β = 0.12; P=0.041) and family caregivers (β = 0.32; P=0.002). The results indicate that death anxiety is a common, clinically significant problem in patients with advanced cancer and their family caregivers, emphasizing the need for targeted psychological support.

12 June 2024 in Death Studies
Verified
Journal Article
Closed access
RPRebecca Philipp
Rebecca Philipp
CWCharlotte Walbaum
Charlotte Walbaum
SVSigrun Vehling
Sigrun Vehling
Individuals with life-limiting physical illness experience lower mental health due to existential distress (e.g., demoralization, death anxiety) and mental disorders (e.g., depression, anxiety). Psychodynamic psychotherapy may be helpful in alleviating such distress by focusing patients' unconscious emotional and relational motivations. There is yet limited knowledge on the application of psychodynamic psychotherapies in this population. We systematically searched electronic databases and analyzed results using meta-ethnography. Of 15,112 identified records, we included 31 qualitative studies applying psychodynamic psychotherapies (n = 69, mean age: 49.3 [SD = 16.9)], 56% female). Psychodynamic treatment in this population can be beneficial when considering modification of the treatment setting to the illness reality, balancing needs for autonomy and separation in light of helplessness and death anxiety, and careful integration of supportive interventions and conflict-oriented interventions (e.g., exploring relational issues that interfere with mourning illness-related loss). We discuss future directions for the development and evaluation of treatments specific to serious physical illness.

1 January 2025 in European Journal of Cancer Care
Verified
Journal Article
Open access
RPRebecca Philipp
Rebecca Philipp
CWCharlotte Walbaum
Charlotte Walbaum
CBCarsten Bokemeyer
Carsten Bokemeyer
MHMartin Härter
Martin Härter
KOKarin Oechsle
Karin Oechsle
SVSigrun Vehling
Sigrun Vehling
Objective: Prevalence rates of depression and anxiety in patients with a serious physical illness are high. Psychodynamic psychotherapies show potential in mitigating such psychological distress because they address hindering relational experiences and unconscious conflicts that may impair patients’ capacity to cope with illness‐related distress. We investigated the efficacy of psychodynamic psychotherapy for symptoms of depression and anxiety in patients with serious physical illness. Methods: We conducted a systematic literature search to identify randomized controlled trials and quasi‐experiments of psychodynamic psychotherapies in adults with serious physical illness. We conducted random‐effects meta‐analyses and narrative summaries. Results: We identified 15,112 records and included 5 RCTs ( n = 648, mean age: 52.4 years, 69% female). Meta‐analyses showed no significant differences between psychodynamic and standard treatment for the reduction of depressive symptoms in serious physical illness (SMD = −0.24, 95% CI: −0.87 to 0.39). No meta‐analysis was calculated for anxiety symptoms due to the small number of studies investigating this outcome. Conclusion: Quantitative evidence for the efficacy of psychodynamic psychotherapy in this population is inconclusive. More research is needed with regard to effective intervention length and adequate outcome measures, especially in patients with incurable illness.